A detailed history of Zeke Capital Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Zeke Capital Advisors, LLC holds 2,761 shares of AMGN stock, worth $871,205. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,761
Previous 3,475 20.55%
Holding current value
$871,205
Previous $784,000 7.53%
% of portfolio
0.05%
Previous 0.06%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $163,527 - $207,781
-714 Reduced 20.55%
2,761 $725,000
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $673 - $759
-3 Reduced 0.09%
3,475 $784,000
Q2 2022

Aug 09, 2022

BUY
$230.71 - $256.74 $167,495 - $186,393
726 Added 26.38%
3,478 $847,000
Q1 2022

May 13, 2022

BUY
$219.27 - $242.57 $603,431 - $667,552
2,752 New
2,752 $666,000
Q1 2020

Apr 24, 2020

SELL
$182.24 - $241.7 $1.6 Million - $2.13 Million
-8,805 Closed
0 $0
Q4 2019

Jan 17, 2020

SELL
$189.21 - $243.2 $2,270 - $2,918
-12 Reduced 0.14%
8,805 $2.12 Million
Q3 2019

Oct 18, 2019

SELL
$174.11 - $208.62 $210,847 - $252,638
-1,211 Reduced 12.08%
8,817 $1.71 Million
Q2 2019

Jul 24, 2019

SELL
$166.7 - $195.41 $234,546 - $274,941
-1,407 Reduced 12.3%
10,028 $1.85 Million
Q1 2019

Apr 29, 2019

BUY
$180.87 - $203.88 $2,351 - $2,650
13 Added 0.11%
11,435 $2.17 Million
Q4 2018

Feb 11, 2019

SELL
$178.4 - $208.25 $616,907 - $720,128
-3,458 Reduced 23.24%
11,422 $2.22 Million
Q3 2018

Nov 08, 2018

SELL
$185.29 - $208.89 $2,964 - $3,342
-16 Reduced 0.11%
14,880 $3.09 Million
Q2 2018

Jul 24, 2018

SELL
$166.05 - $186.51 $259,536 - $291,515
-1,563 Reduced 9.5%
14,896 $2.75 Million
Q1 2018

May 03, 2018

BUY
$169.43 - $198.0 $726,176 - $848,628
4,286 Added 35.21%
16,459 $2.81 Million
Q4 2017

Feb 14, 2018

SELL
$168.79 - $188.59 $133,850 - $149,551
-793 Reduced 6.12%
12,173 $2.12 Million
Q3 2017

Nov 09, 2017

BUY
$167.29 - $191.0 $2.17 Million - $2.48 Million
12,966
12,966 $2.42 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Zeke Capital Advisors, LLC Portfolio

Follow Zeke Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zeke Capital Advisors, LLC with notifications on news.